الفهرس 
Bilirubin
Neonatal jaundiceOnly 14 pages are availabe for public view
 |  | from | 184 |  |  |
| | | from | 184 | | |
Abstract
Summary Neonatal hyperbilirubinemia is one of the most prevalent clinical conditions in neonates. Between 60%–80% of healthy infants are expected to present with neonatal jaundice. In a proportion of infants, jaundice may become severe, progressing to acute bilirubin encephalopathy (ABE) or kernicterus with a significant risk of neonatal mortality. Surviving infants may acquire long-term neurodevelopmental sequelae such as cerebral palsy, sensorineural hearing loss, intellectual difficulties or gross developmental delays. The American Academic of Pediatrics (AAP) recommends that newborns discharged within 48 h should have a follow-up visit after 48–72 h for any significant jaundice or other problems. Available clinical guidelines recommend early detection of infants at risk of severe hyperbilirubinemia to facilitate timely and effective prevention of the associated burden. Reliable predictive markers enabling physicians to identify which newborns will develop significant hyperbilirubinemia have become mandatory for prevention of severe hyperbilirunemia and its seious complications. The aim of this study was to evaluate the significance of cord blood bilirubin, albumin, bilirubin/albumin ratio and hydrogen peroxide as early predictors of significant neonatal hyperbilirubinemia.